3.655USD-7.35%Mkt Cap: 416.84M USDP/E: —Last update: 2026-06-01
Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap416.84M USD
Enterprise Value195.19M USD
Revenue (TTM)618.00K USD
Gross Profit-90.64M USD
Net Income (TTM)-103.12M USD
Revenue/Share0.0080 USD
Last Price3.655 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees163
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.42
PEG—
EV/EBITDA-1.68
EV/Revenue315.84
P/S727.09
P/B1.29
EPS (TTM)-1.41
EPS (Forward)-1.15
52W Range
1.96040% of range6.160
52W High6.160 USD
52W Low1.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-37211.84%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.81%
ROA-38.63%
Growth
Revenue Growth-77.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.48M USD
CapEx (TTM)12.75M USD
FCF Margin-9511.61%
FCF Yield-14.10%
Net Debt-266.70M USD
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity0.02
Current Ratio8.74
Quick Ratio8.61
Book Value/Sh3.047 USD
Cash/Share2.376 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 17, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)12.93 USD
Target Range6.000 USD – 18.00 USD
# Analysts15
Ownership
Shares Out.114.05M
Float74.34M
Insiders10.81%
Institutions76.65%
Short Interest
Short Ratio8.3d
Short % Float13.21%
Short % Out.11.06%
Shares Short12.62M
Short (prev mo.)13.67M
Technical
SMA 504.156 (-12.1%)
SMA 2003.627 (+0.8%)
Beta1.76
S&P 52W Chg27.94%
Avg Vol (30d)1.45M
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)48.1
MACD-0.0429
MACD Signal-0.0953
MACD Hist.+0.0523
BB Upper4.170 USD
BB Middle3.858 USD
BB Lower3.547 USD
BB Width16.13%
ATR (14)0.2737 USD
Vol Ratio (20d)0.51x